ABEONA THERAPEUTICS INC. Quarterly Interest Expense in USD from Q1 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Abeona Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q4 2024.
  • Abeona Therapeutics Inc. Interest Expense for the quarter ending December 31, 2024 was $1.08M, a 893% increase year-over-year.
  • Abeona Therapeutics Inc. Interest Expense for the twelve months ending December 31, 2024 was $4.21M, a 907% increase year-over-year.
  • Abeona Therapeutics Inc. annual Interest Expense for 2024 was $4.21M, a 907% increase from 2023.
  • Abeona Therapeutics Inc. annual Interest Expense for 2023 was $418K, a 43.2% decline from 2022.
  • Abeona Therapeutics Inc. annual Interest Expense for 2022 was $736K, a 79.9% decline from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $4.21M $1.08M +$973K +893% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 $3.24M $1.1M +$997K +950% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $2.24M $1.07M +$969K +941% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.27M $952K +$851K +843% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $418K $109K -$69K -38.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 $487K $105K -$52K -33.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $539K $103K -$97K -48.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $636K $101K -$100K -49.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $736K $178K +$125K +236% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $611K $157K -$526K -77% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $1.14M $200K -$1.3M -86.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $2.44M $201K -$1.22M -85.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.66M $53K -$1.34M -96.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $4.99M $683K -$644K -48.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $5.64M $1.5M +$700K +87.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $4.94M $1.42M +$820K +137% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $4.12M $1.39M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.33M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $800K Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $600K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.